title: Myostatin inhibition: a new treatment for androgen deprivation-induced sarcopenia?
authors.affiliation: Department of Medicine Austin Health, University of Melbourne, and Endocrine Unit, Austin Health, Heidelberg, Victoria 3052, Australia.
authors.forename: Mathis
authors.initials: M
authors.lastname: Grossmann
mesh_terms: D000726:Androgen Antagonists / Q000009:adverse effects*; D015992:Body Mass Index; D006801:Humans; D007141:Immunoglobulin Fc Fragments / Q000009:adverse effects*; D008297:Male; D018482:Muscle, Skeletal / Q000187:drug effects*; D055435:Myostatin / Q000037:antagonists & inhibitors*; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D011993:Recombinant Fusion Proteins / Q000009:adverse effects*
chemical_list: C000594655:AMG 745; D000726:Androgen Antagonists; D007141:Immunoglobulin Fc Fragments; C525911:MSTN protein, human; D055435:Myostatin; D011993:Recombinant Fusion Proteins